Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

New
New Allied Market Research

Blood Culture Test Market by Product (Consumables, Instruments, and Software & Services), Method (Conventional and Automated), and Application (Bacterial, Fungal, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

A11114
Pages: 259
Apr 2021 | 125 Views
 
Author(s) : Ravi Telugunta & Linu Dash
Tables: 122
Charts: 46
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Blood Culture Test Market

Request Now !

Blood Culture Test Market Overview:

The global blood culture test market generated $3,900.00 million in 2019, and is projected to reach $8,186.15 million by 2027, growing at a CAGR of 9.3% from 2020 to 2027. The blood culture tests is a procedure used to detect the presence of microorganism such as fungi or bacteria in the blood. It diagnoses the causative agent responsible for bloodstream infection and provides a suitable therapeutic approach. Blood culture tests are often done in conjunction with other diagnostic test such as chemical analysis and complete blood count.

Increase in geriatric population; rise in prevalence of infectious disease, bloodstream infection (BSIs), and sepsis, and surge in demand of diagnostic tests are the key factors that drive the growth of the global blood culture test market. It has been observed from the report of the World Health Organization that 85% of the deaths from sepsis occur in low- and middle-income countries.  In addition, surge in demand for blood culture tests, rise in awareness about healthcare to prevent the risk of infectious diseases, upsurge in government initiatives for development & manufacturing of blood culture tests product and increase in investment in R&D activities by various healthcare companies contribute toward the growth of the market. For instance, F. Hoffmann-La Roche Ltd., a biotech company, invested across $9.27 billion in R&D in 2019. Furthermore, implementation of favorable regulatory environment for the development and manufacturing of advanced diagnostic products, which include blood culture test products is expected to drive the growth of the market during the forecast period. However, high cost of automated blood culture instruments and lack of skilled professionals & laboratory technicians are expected to hinder the growth of the market. The, surge in adoption of new technology is expected to provide remunerative opportunities for the expansion of the global blood culture test market during the forecast period.

Blood-Culture-Test-Market-2020-2027

Get more information on this report : Request Sample Pages

As per the data published by the Health and Human Services (HHS), in the U.S., about 20% increase was registered in Medicare enrollment rates in the past one year. However, 40% rise was witnessed in the rate of sepsis-related hospital admissions among the beneficiaries in 2018. Around 270,000 Americans die every year as a result of sepsis. This is expected to propel the demand for blood culture tests in the coming years. Moreover, with the help of advancement in technology, Luminex Corporation, a biotechnology company having application in life-science, launched Verigene, which has 30 targets and provides results for six different resistant genes for Gram negative of CTX-M-ESBL (CefiTaXime Extended Spectrum Beta-Lactamase). Thus, with the rise in adoption of new technology in healthcare sectors, propels the blood culture test market growth.

Blood Culture Test Market Segmentation

The global blood culture test market is segmented into product, method, application, and region. By product, the market is divided into consumables, instruments, and software & services. On the basis of method, the market is fragmented into conventional and automated. The applications covered in the study include bacterial, fungal, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, Russia, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).

Segment review

Depending on type of product, , the consumables segment dominated the global blood culture test market in 2019, and is anticipated to continue this trend during the forecast period, due to increase in demand for blood culture media, assay, kits, and reagents. However, the instrument segment is expected to witness considerable growth during the forecast period. This is attributed to the fact that instruments used in hospitals and diagnostic laboratories facilitate rapid result and high accuracy for detection of bacterial and fungal. 

On the basis of the type of method, the conventional segment exhibited the highest growth in 2019, and is anticipated to lead in the near future. This is attributed to the extensive use in independent clinical laboratories and increase in application of this conventional blood culture method in hospitals & pathology laboratories. However, the automated segment is expected to witness considerable growth during the forecast period, due to increase in investments in R&D for development of new products, quick & accurate results, and advancements in blood culture test devices.

Blood Culture Test Market
By Product

Your browser does not support the canvas element.

Consumables segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of the type of application, the bacterial segment exhibited the highest growth in 2019, and is anticipated to lead in the near future, owing to the fact that bacterial infection is one of the major causes of bloodstream infection and sepsis. However, the fungal segment is expected to witness considerable growth during the forecast period, due to increase in the prevalence of sepsis and bloodstream infection across the globe.

Blood Culture Test Market
By Method

Your browser does not support the canvas element.

Conventional segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America accounted for a major share in the blood culture test market in 2019, and is expected to maintain its dominance during the forecast period, owing to rise in prevalence of bloodstream infection and presence of advanced healthcare infrastructure. Furthermore, rise in awareness & acceptance of novel diagnostic method, strong economic growth, and increase in demand for advanced healthcare facilities are contributing toward growth of the market. Moreover, upsurge in R&D activities to develop novel blood culture tests and presence of major players operating in the region fuel the growth of the blood culture test market. However, Asia-Pacific is expected to register highest CAGR of 11.70% from 2020 to 2027, owing to increasing target population and developing healthcare infrastructure.

Blood Culture Test Market
By Application

Your browser does not support the canvas element.

Bacterial segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

The key players operating in the global blood culture test market include Autobio Diagnostics Co., Ltd, Becton, Dickinson and company (BD), bioMerieux SA, Bruker Corporation, F. Hoffmann-La Roche Ltd, Luminex Corporation, Neogen Corporation (Abtek Biologicals),  OpGen Inc., T2 Biosystems, Inc. and Thermo Fisher Scientific Inc. 

Blood Culture Test Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2019 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the blood culture test market, and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the market from 2019 to 2027 to enable stakeholders to capitalize on the prevailing blood culture test market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the blood culture test industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the blood culture test market.

Key Market Segments

By Product

  • Consumables
  • Instruments
  • Software & Services

By Method

  • Conventional 
  • Automated 

By Application

  • Bacterial
  • Fungal
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s Five Forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of infectious diseases, bloodstream infection and sepsis
3.5.1.2.Rise in demand for advanced diagnostic techniques
3.5.1.3.Increase in R&D activities and strict regulation from government
3.5.1.4.Growing worldwide geriatric population

3.5.2.Restraints

3.5.2.1.High cost of automated blood culture instruments
3.5.2.2.Lack of skilled professionals and laboratory technicians

3.5.3.Opportunity

3.5.3.1.Increase in adoption of new technology

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the blood culture tests market

CHAPTER 4:BLOOD CULTURE TEST, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Consumables

4.2.1.Market size and forecast, by region
4.2.2.Market analysis, by country

4.3.Instruments

4.3.1.Market size and forecast, by region
4.3.2.Market analysis, by country

4.4.Software and Services

4.4.1.Market size and forecast, by region
4.4.2.Market analysis, by country

CHAPTER 5:BLOOD CULTURE TESTS MARKET, BY METHOD

5.1.Overview

5.1.1.Market size and forecast

5.2.Conventional

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Automated 

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

CHAPTER 6:BLOOD CULTURE TESTS MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Bacterial

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Fungal

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Other

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:BLOOD CULTURE TEST MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.North America market size and forecast, by product
7.2.2.North America market size and forecast, by method
7.2.3.North America market size and forecast, by application
7.2.4.North America market size and forecast, by country
7.2.5.U.S.

7.2.5.1.U.S. market size and forecast, by product
7.2.5.2.U.S. market size and forecast, by method
7.2.5.3.U.S. market size and forecast, by application

7.2.6.Canada

7.2.6.1.Canada market size and forecast, by product
7.2.6.2.Canada market size and forecast, by method
7.2.6.3.Canada market size and forecast, by application

7.2.7.Mexico

7.2.7.1.Mexico market size and forecast, by product
7.2.7.2.Mexico market size and forecast, by method
7.2.7.3.Mexico market size and forecast, by application

7.3.Europe

7.3.1.Europe market size and forecast, by product
7.3.2.Europe market size and forecast, by method
7.3.3.Europe market size and forecast, by application
7.3.4.Europe market size and forecast, by country
7.3.5.Germany

7.3.5.1.Germany market size and forecast, by product
7.3.5.2.Germany market size and forecast, by method
7.3.5.3.Germany market size and forecast, by application

7.3.6.France

7.3.6.1.France market size and forecast, by product
7.3.6.2.France market size and forecast, by method
7.3.6.3.France market size and forecast, by application

7.3.7.UK

7.3.7.1.UK market size and forecast, by product
7.3.7.2.UK market size and forecast, by method
7.3.7.3.UK market size and forecast, by application

7.3.8.Italy

7.3.8.1.Italy market size and forecast, by product
7.3.8.2.Italy market size and forecast, by method
7.3.8.3.Italy market size and forecast, by application

7.3.9.Spain

7.3.9.1.Spain market size and forecast, by product
7.3.9.2.Spain market size and forecast, by method
7.3.9.3.Spain market size and forecast, by application

7.3.10.Rest of Europe

7.3.10.1.Rest of Europe market size and forecast, by product
7.3.10.2.Rest of Europe market size and forecast, by method
7.3.10.3.Rest of Europe market size and forecast, by application

7.4.Asia-Pacific

7.4.1.Asia-Pacific market size and forecast, by product
7.4.2.Asia-Pacific market size and forecast, by method
7.4.3.Asia-Pacific market size and forecast, by application
7.4.4.Asia-Pacific market size and forecast, by country
7.4.5.Japan

7.4.5.1.Japan market size and forecast, by product
7.4.5.2.Japan market size and forecast, by method
7.4.5.3.Japan market size and forecast, by application

7.4.6.China

7.4.6.1.China market size and forecast, by product
7.4.6.2.China market size and forecast, by method
7.4.6.3.China market size and forecast, by application

7.4.7.Australia

7.4.7.1.Australia market size and forecast, by product
7.4.7.2.Australia market size and forecast, by method
7.4.7.3.Australia market size and forecast, by application

7.4.8.India

7.4.8.1.India market size and forecast, by product
7.4.8.2.India market size and forecast, by method
7.4.8.3.India market size and forecast, by application

7.4.9.South Korea

7.4.9.1.South Korea market size and forecast, by product
7.4.9.2.South Korea market size and forecast, by method
7.4.9.3.South Korea market size and forecast, by application

7.4.10.Rest of Asia-Pacific

7.4.10.1.Rest of Asia-Pacific market size and forecast, by product
7.4.10.2.Rest of Asia-Pacific market size and forecast, by method
7.4.10.3.Rest of Asia-Pacific market size and forecast, by application

7.5.LAMEA

7.5.1.LAMEA market size and forecast, by product
7.5.2.LAMEA market size and forecast, by method
7.5.3.LAMEA market size and forecast, by application
7.5.4.LAMEA market size and forecast, by country
7.5.5.Brazil

7.5.5.1.Brazil market size and forecast, by product
7.5.5.2.Brazil market size and forecast, by method
7.5.5.3.Brazil market size and forecast, by application

7.5.6.Saudi Arabia

7.5.6.1.Saudi Arabia market size and forecast, by product
7.5.6.2.Saudi Arabia market size and forecast, by method
7.5.6.3.Saudi Arabia market size and forecast, by application

7.5.7.South Africa

7.5.7.1.South Africa market size and forecast, by product
7.5.7.2.South Africa market size and forecast, by method
7.5.7.3.South Africa market size and forecast, by application

7.5.8.Rest of LAMEA

7.5.8.1.Rest of LAMEA market size and forecast, by product
7.5.8.2.Rest of LAMEA market size and forecast, by method
7.5.8.3.Rest of LAMEA market size and forecast, by application

CHAPTER 8:COMPANY PROFILES

8.1.AUTOBIO DIAGNOSTICS CO. LTD

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments

8.2.BECTON, DICKINSON AND COMPANY

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.BIOMÉRIEUX SA

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.BRUKER CORPORATION

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.F. HOFFMANN-LA ROCHE LTD

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.LUMINEX CORPORATION

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.NEOGEN Corporation (Abtek Biologicals)

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.OPGEN INC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.T2 BIOSYSTEMS, INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.THERMO FISHER SCIENTIFIC, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.GLOBAL BLOOD CULTURE TEST MARKET FOR CONSUMABLES, BY REGION, 2019–2027 ($MILLION)
TABLE 03.GLOBAL BLOOD CULTURE TEST MARKET FOR INSTRUMENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL BLOOD CULTURE TEST MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 05.GLOBAL BLOOD CULTURE TESTS MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 06.GLOBAL BLOOD CULTURE TESTS MARKET FOR CONVENTIONAL, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL BLOOD CULTURE TESTS MARKET FOR AUTOMATED , BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.GLOBAL BLOOD CULTURE TESTS MARKET FOR BACTERIAL, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GLOBAL BLOOD CULTURE TESTS MARKET FOR FUNGAL, BY REGION, 2019–2027 ($MILLION)
TABLE 11.GLOBAL BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIA DETECTION, BY REGION, 2019–2027 ($MILLION)
TABLE 12.BLOOD CULTURE TEST MARKET, BY REGION, 2019–2027, ($MILLION)
TABLE 13.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 14.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 15.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 16.NORTH AMERICA BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 17.U.S. BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 18.U.S. BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
U.S BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 19.CANADA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 20.CANADA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 21.CANADA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 22.MEXICO BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 23.MEXICO BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 24.MEXICO BLOOD CULTURE TEST MARKET, BY APPLICATIONE, 2019-2027, ($MILLION)
TABLE 25.EUROPE BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 26.EUROPE BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 27.EUROPE BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 28.EUROPE BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 29.GERMANY BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 30.GERMANY BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 31.GERMANY BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 32.FRANCE BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 33.FRANCE BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 34.FRANCE BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 35.UK BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 36.UK BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 37.UK BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 38.ITALY BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 39.ITALY BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 40.ITALY BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 41.SPAIN BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 42.SPAIN BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 43.SPAIN BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 44.REST OF EUROPE BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 45.REST OF EUROPE BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 46.REST OF EUROPE BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 47.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 48.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 49.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 50.ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 51.JAPAN BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 52.JAPAN BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 53.JAPAN BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 54.CHINA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 55.CHINA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 56.CHINA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 57.AUSTRALIA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 58.AUSTRALIA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 59.AUSTRALIA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 60.INDIA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 61.INDIA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 62.INDIA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 63.SOUTH KOREA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 64.SOUTH KOREA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 65.SOUTH KOREA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 69.LAMEA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 70.LAMEA BLOOD CULTURE TEST MARKET, BY METHOD, 2019–2027, ($MILLION)
TABLE 71.LAMEA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 72.LAMEA BLOOD CULTURE TEST MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 73.BRAZIL BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 74.BRAZIL BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 75.BRAZIL BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 76.SAUDI ARABIA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 77.SAUDI ARABIA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 78.SAUDI ARABIA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 79.SOUTH AFRICA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 80.SOUTH AFRICA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 81.SOUTH AFRICA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 82.REST OF LAMEA BLOOD CULTURE TEST MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 83.REST OF LAMEA BLOOD CULTURE TEST MARKET, BY METHOD, 2019-2027, ($MILLION)
TABLE 84.REST OF LAMEA BLOOD CULTURE TEST MARKET, BY APPLICATION, 2019-2027, ($MILLION)
TABLE 85.AUTOBIO: COMPANY SNAPSHOT
TABLE 86.AUTOBIO: OPERATING SEGMENTS
TABLE 87.AUTOBIO: PRODUCT PORTFOLIO
TABLE 88.AUTOBIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89.BD: COMPANY SNAPSHOT
TABLE 90.BD: OERATING SEGMENT
TABLE 91.BD: PRODUCT PORTFOLIO
TABLE 92.BIOMÉRIEUX: COMPANY SNAPSHOT
TABLE 93.BIOMÉRIEUX: OPERATING SEGMENTS
TABLE 94.BIOMÉRIEUX: PRODUCT PORTFOLIO
TABLE 95.BIOMÉRIEUX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96.BRUKER: COMPANY SNAPSHOT
TABLE 97.BRUKER: OPERATING BUSINESS SEGMENTS
TABLE 98.BRUKER: PRODUCT PORTFOLIO
TABLE 99.BRUKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.ROCHE: COMPANY SNAPSHOT
TABLE 101.ROCHE : OPERATING SEGMENTS
TABLE 102.ROCHE : PRODUCT PORTFOLIO
TABLE 103.ROCHE : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104.LUMINEX: COMPANY SNAPSHOT
TABLE 105.LUMINEX: OPERATING SEGMENTS
TABLE 106.LUMINEX: PRODUCT PORTFOLIO
TABLE 107.LUMINEX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108.NEOGEN: COMPANY SNAPSHOT
TABLE 109.NEOGEN: OPERATING SEGMENT
TABLE 110.NEOGEN: PRODUCT PORTFOLIO
TABLE 111.NEOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112.OPGEN : COMPANY SNAPSHOT
TABLE 113.OPGEN: OPERATING SEGMENTS
TABLE 114.OPGEN: PRODUCT PORTFOLIO
TABLE 115.T2 BIOSYSTEMS: COMPANY SNAPSHOT
TABLE 116.T2 BIOSYSTEMS: OPERATING SEGMENTS
TABLE 117.T2 BIOSYSTEMS : PRODUCT PORTFOLIO
TABLE 118.T2 BIOSYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119.THERMO FISHER: COMPANY SNAPSHOT
TABLE 120.THERMO FISHER.: OPERATING SEGMENTS
TABLE 121.THERMO FISHER: PRODUCT PORTFOLIO
TABLE 122.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.GLOBAL BLOOD CULTURE TESTS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TEST MARKET FOR INSTRUMENTS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TEST MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR CONVENTIONAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR AUTOMATED , BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR BACTERIAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR FUNGAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF GLOBAL BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIA DETECTION, BY COUNTRY, 2019 & 2027 (%)
FIGURE 21.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 22.BD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 23.BD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 24.BIOMÉRIEUX: NET SALES, 2018–2020 ($MILLION)
FIGURE 25.BIOMÉRIEUX: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 26.BIOMÉRIEUX: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 27.BRUKER: NET SALES, 2017–2019 ($MILLION)
FIGURE 28.BRUKER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 29.BRUKER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 30.ROCHE: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.ROCHE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 32.ROCHE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.LUMINEX: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.LUMINEX: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.LUMINEX: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.NEOGEN: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.NEOGEN: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 38.NEOGEN: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 39.OPGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.OPGEN: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 41.T2 BIOSYSTEMS: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.T2 BIOSYSTEMS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 43.T2 BIOSYSTEMS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 44.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 46.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)

 
 

The blood culture tests market is expected to exhibit high growth potential in the future. This is attributed to factors such as technological advancements in automatic blood culture test instrument; rise in prevalence of infectious diseases, bloodstream infection, and sepsis; increase in geriatric population; and surge in awareness among consumers regarding healthcare sectors. Moreover, the blood culture tests have gained high traction in the healthcare industry over years, as they are intended for diagnosis, treatment, or management of infectious diseases.

As per the analysis in the report, the market in Asia-Pacific is projected to register highest growth rate, due to presence of large population base coupled with rise in prevalence of chronic diseases, increase in awareness about wearable patches, and rise in disposable income. 

In addition, high cost of automated blood culture instruments and lack of skilled professionals & laboratory technicians are anticipated to restrain the market growth during the forecast period.

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The top companies that hold the market share in blood culture tests Market are Autobio Diagnostics Co., Ltd, Becton, Dickinson and company (BD), bioMerieux SA, Bruker Corporation, F. Hoffmann-La Roche Ltd, Luminex Corporation, Neogen Corporation (Abtek Biologicals), OpGen Inc., T2 Biosystems, Inc. and Thermo Fisher Scientific Inc.

A. Consumables is the most influencing segment growing in the blood culture tests market report

A. The key trends in the blood culture tests Market are increase in prevelnce of Bloodstream infection, rise in demad of diagnostic tests and advancement in R&D for healthcare sector

A. The base year for the report is 2019

A. Yes, blood culture tests companies are profiled in the report

A. The total market value of blood culture tests Market is $3,900 million in 2019

A. The forecast period in the report is from 2020 to 2027

A. The market value of blood culture tests Market in 2020 was $4,391.40 Million

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Blood Culture Test Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers